Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 7 12 2021
medline: 27 1 2022
entrez: 6 12 2021
Statut: ppublish

Résumé

BACKGROUND : The European Society of Gastrointestinal Endoscopy (ESGE) has developed a core curriculum for high quality optical diagnosis training for practice across Europe. The development of easy-to-measure competence standards for optical diagnosis can optimize clinical decision-making in endoscopy. This manuscript represents an official Position Statement of the ESGE aiming to define simple, safe, and easy-to-measure competence standards for endoscopists and artificial intelligence systems performing optical diagnosis of diminutive colorectal polyps (1 - 5 mm). METHODS : A panel of European experts in optical diagnosis participated in a modified Delphi process to reach consensus on Simple Optical Diagnosis Accuracy (SODA) competence standards for implementation of the optical diagnosis strategy for diminutive colorectal polyps. In order to assess the clinical benefits and harms of implementing optical diagnosis with different competence standards, a systematic literature search was performed. This was complemented with the results from a recently performed simulation study that provides guidance for setting alternative competence standards for optical diagnosis. Proposed competence standards were based on literature search and simulation study results. Competence standards were accepted if at least 80 % agreement was reached after a maximum of three voting rounds. RECOMMENDATION 1:  In order to implement the leave-in-situ strategy for diminutive colorectal lesions (1-5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 90 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1-5 mm in the rectosigmoid. Histopathology is used as the gold standard.Level of agreement 95 %. RECOMMENDATION 2:  In order to implement the resect-and-discard strategy for diminutive colorectal lesions (1-5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 80 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1-5 mm. Histopathology is used as the gold standard.Level of agreement 100 %. CONCLUSION : The developed SODA competence standards define diagnostic performance thresholds in relation to clinical consequences, for training and for use when auditing the optical diagnosis of diminutive colorectal polyps.

Identifiants

pubmed: 34872120
doi: 10.1055/a-1689-5130
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-99

Informations de copyright

European Society of Gastrointestinal Endoscopy. All rights reserved.

Déclaration de conflit d'intérêts

R. Bisschops has received research support from Cook and Medtronic, and financial support for symposium organization from Cook, Boston Scientific, Olympus, and Erbe (2009–2109), and speakers’ fees from Boston Scientific and Medtronic (2009–2019). E. Coron has received speakerʼs fees from Fujifilm (2018–2020). E. Dekker has received speaker’s fees from Roche (2018), Norgine (2019), Olympus and GI Supply (both 2019 to 2020), and Fujifilm (2020), and has provided consultancy to Fujifilm (2018), CPP-FAP (2019), GI Supply (2019 to 2020), Olympus (2020 to present), PAION and Ambu (both 2021); she received a research grant from Fujifilm (2017 to 2020) and her department has equipment on loan from Fujifilm (2017 to present) and Olympus (2021). M. Dinis-Ribeiro receives an educational grant from Olympus (2020 to present) and a research grant from Fujifilm (2020 to present); he is co-editor in-chief of

Auteurs

Britt B S L Houwen (BBSL)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Cesare Hassan (C)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Endoscopy Unit, IRCCS Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

Veerle M H Coupé (VMH)

Department of Epidemiology and Data Science, Amsterdam University Medical Center, location VUmc, Amsterdam, The Netherlands.

Marjolein J E Greuter (MJE)

Department of Epidemiology and Data Science, Amsterdam University Medical Center, location VUmc, Amsterdam, The Netherlands.

Yark Hazewinkel (Y)

Department of Gastroenterology and Hepatology, Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands.

Jasper L A Vleugels (JLA)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Giulio Antonelli (G)

Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, "Sapienza" University of Rome, Rome, Italy.
Gastroenterology and Digestive Endoscopy Unit, Ospedale dei Castelli Hospital, Ariccia, Rome, Italy.

Marco Bustamante-Balén (M)

Gastrointestinal Endoscopy Unit, Digestive Diseases Department, La Fe Polytechnic University Hospital, Valencia, Spain.
Gastrointestinal Endoscopy Research Group, La Fe Health Research Institute, Valencia, Spain.

Emmanuel Coron (E)

Institut des Maladies de l'Appareil Digestif, Nantes, France.

George A Cortas (GA)

Division of Gastroenterology, University of Balamand, Faculty of Medicine, St. George Hospital University Medical Center, Beirut, Lebanon.

Mario Dinis-Ribeiro (M)

Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
RISE@CI-IPOP (Health Research Network), Porto, Portugal.

Daniela E Dobru (DE)

Gastroenterology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Targu Mures, Romania.

James E East (JE)

Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Division of Gastroenterology and Hepatology, Mayo Clinic Healthcare, London.

Marietta Iacucci (M)

Institute of Translational of Medicine, Institute of Immunology and Immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Rodrigo Jover (R)

Servicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Universidad Miguel Hernández, Alicante, Spain.

Roman Kuvaev (R)

Endoscopy Department, Yaroslavl Regional Cancer Hospital, Yaroslavl, Russian Federation.
Department of Gastroenterology, Faculty of Additional Professional Education, N.A. Pirogov Russian National Research Medical University, Moscow, Russian Federation.

Helmut Neumann (H)

Department of Medicine I, University Medical Center Mainz, Mainz, Germany.
GastroZentrum, Lippe, Germany.

Maria Pellisé (M)

Department of Gastroenterology, Hospital Clínic de Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

Ignasi Puig (I)

Digestive Diseases Department, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Spain.
Department of Medicine, Facultat de Ciències de la Salut, Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Manresa, Spain.

Matthew D Rutter (MD)

Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, UK.
University Hospital of North Tees , Stockton-on-Tees, UK.

Brian Saunders (B)

Department of Gastroenterology, St Mark's Hospital and Academic Institute, Harrow, UK.

David J Tate (DJ)

Department of Gastroenterology and Hepatology, University of Ghent, Ghent, Belgium.
University Hospital Ghent, Ghent, Belgium.

Yuichi Mori (Y)

Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
Section of Gastroenterology, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.

Gaius Longcroft-Wheaton (G)

Portsmouth Hospitals University NHS Trust, Cosham, Portsmouth, UK.

Raf Bisschops (R)

Department of Gastroenterology and Hepatology, Catholic University of Leuven, (KUL), TARGID, University Hospital Leuven, Leuven, Belgium.

Evelien Dekker (E)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH